Related Experiment Videos

Acute respiratory distress syndrome in children with malignancy--can we predict outcome?

R Ben-Abraham1, A A Weinbroum, A Augerten

  • 1Department of Anesthesia and Critical Care Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.

Insights

Early respiratory indicators like peak inspiratory pressure and PEEP can predict survival in pediatric cancer patients with acute respiratory distress syndrome (ARDS). These findings aid in timely interventions for critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pediatric Oncology
  • Respiratory Medicine

Background:

  • Acute Respiratory Distress Syndrome (ARDS) poses a significant threat to children with hematologic-oncologic malignancies.
  • Identifying early predictors of mortality is crucial for improving outcomes in this vulnerable population.

Purpose of the Study:

  • To identify early respiratory parameters that predict mortality in pediatric patients with malignancy and ARDS.
  • To establish a basis for early therapeutic interventions in this high-risk group.

Main Methods:

  • Retrospective chart review of pediatric patients with malignancy and ARDS requiring mechanical ventilation.
  • Analysis of respiratory data, including peak inspiratory pressure, PEEP, ventilation index, PaO(2)/FIO(2), and P(A-a)O(2).
  • Evaluation of data from January 1987 to January 1997 in a pediatric intensive care unit.

Main Results:

  • Out of 17 identified children, 35.3% survived.
  • Sepsis syndrome was prevalent, affecting 70.6% of patients.
  • Peak inspiratory pressure, PEEP, and ventilation index distinguished outcomes by day 3.
  • Oxygenation efficiency parameters (PaO(2)/FIO(2), P(A-a)O(2)) showed a relationship with outcome from day 8.

Conclusions:

  • Early mechanical ventilation parameters (peak inspiratory pressure, PEEP, ventilation index) can predict survival by day 3 in children with malignancy and ARDS.
  • These findings support the early application of supportive and nonconventional therapies.
  • Timely identification of non-survivors can guide critical care decisions.
Abstract

Related Concept Videos